VitaPCR™ to be Featured on CNBC
Credo Diagnostics Biomedical Pte. Ltd., a groundbreaking point-of-care rapid molecular diagnostic company, will be featured in the newest episode of Advancements with Ted Danson that will broadcast Nationwide via CNBC on Saturday, September 21st @11:00am ET. The segment will focus on Credo Diagnostics Biomedical’s new molecular diagnostic platform, VitaPCR. Combining speed, accuracy, and ease-of-use required […]
